Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2026Engineering in Life SciencesOpen Access

Less Genome, More Gain: Genome Reduction Enhances Transaminase‐Producing E. coli in a Scale‐Down Bioreactor

View Full Paper
Ask AI
Bookmark
Share

Authors

GAGennaro AvolioSKSimon KlafflRTRalf Takors

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates enhanced transaminase production in E. coli, indicating improved efficiency for large-scale operations.

Key Points

  • This study aims to evaluate the effects of genome reduction on transaminase-producing E. coli in bioreactor systems.
  • Conducted experiments using a scale-down bioreactor system (STR-PFR) comparing genome-reduced strain RM214 to wild-type strain.
  • Evaluated growth under glycerol limitation and starvation with oxygen limitations in later stages.
  • Measured biomass increase and volumetric activity of transaminase production.
  • RM214 exhibited a 53% increase in biomass compared to the wild-type strain.
  • Final volumetric activity improved by 65% in the genome-reduced strain.
  • Lower biomass-specific substrate uptake rates and respiratory parameters were observed, crucial for large-scale optimization.

Cite This Study

Avolio et al. (2026) studied this question.

synapsesocial.com/papers/69f4435b967e944ac55669eehttps://doi.org/10.1002/elsc.70080
View Full Paper
Ask AI
Bookmark
Share